Table 2.
Clinical analysis between the EV group and non-EV group
| Risk factor | Cases (N = 10) N (%) | Non-cases (N = 21) N (%) | P |
|---|---|---|---|
| Caesarean section | 3 (30) | 6 (28.6) | >0.05 |
| Membrane rupture | 2 (20) | 4 (19.0) | >0.05 |
| Prematurity | 8 (80) | 12 (57.1) | >0.05 |
| Hospitalisation (before outbreak) | 26.8 19.0 | 15.8 24.8 | >0.05 |
| Breastmilk | 8 (80) | 5 (23.8) | <0.05 |
| GA (weeks) | 31.7±4.0 | 34.0±4.9 | >0.05 |
| Antibiotics (before outbreak) | 0 (0) | 2 (9.5) | >0.05 |
| PN | 1 (10) | 2 (9.5) | >0.05 |
| Birth weight | 1812.9±1025.1 | 2330.5±1087.5 | >0.05 |
GA, gestational age; PN, parenteral nutrition.